ENT1 blockade by CNX-774 overcomes resistance to DHODH inhibition in pancreatic cancer is a research paper published in Cancer Letters (2022). On theSindex it has a DataRank of 0. It has been cited 28 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: R01CA210439
NCI NIH HHS
Grant: F30 CA265277
National Cancer Institute
Grant: R01CA270234
National Cancer Institute
Grant: U54CA274329
NCI NIH HHS
Grant: T32 CA009476
NCI NIH HHS
Grant: R01 CA163649
NCI NIH HHS
Grant: R01 CA216853
NCI NIH HHS
Grant: R01 CA256911
National Institutes of Health
Grant: 5R01CA210439-05
Targeting the Metabolic Basis of Cachexia in Pancreatic Cancer
National Institutes of Health
Grant: 5F30CA265277-04
Targeting pyrimidine biosynthesis in pancreatic ductal adenocarcinoma
National Institutes of Health
Grant: 1R01CA270234-01
Molecular Basis of ME2-mediated Tumor Suppression in Pancreatic Cancer
National Institutes of Health
Grant: 2R01CA163649-06A1
Targeting MUC1-Mediated Tumor-Stromal Metabolic Cross-Talk in Pancreatic Cancer
National Institutes of Health
Grant: 1U54CA274329-01
Pancreatic Cancer ARTNet Center
National Institutes of Health
FWCI
1.87
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals